Strategies for improving antitumor activity utilizing IL-2: preclinical models and analysis of antitumor activity of lymphocytes from patients receiving IL-2

Biotherapy. 1992;4(3):189-98. doi: 10.1007/BF02174205.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Cytotoxicity, Immunologic / drug effects*
  • Disease Models, Animal
  • Drug Screening Assays, Antitumor
  • Humans
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Lymphokine-Activated / immunology
  • Lymphocytes / immunology*
  • Receptors, Interleukin-2 / physiology
  • Tumor Cells, Cultured

Substances

  • Interleukin-2
  • Receptors, Interleukin-2